Combination of S1, a novel PI3K/mTOR dual inhibitor, with sorafenib to treat small cell lung cancer

WANG Juan, MA Shu-mei, CHEN Xiu-hua, ZHANG San-qi, MEI Qi-bin*

主办：上海医药工业研究院
　　　中国药学会
ISSN 1672-9188   CN 31-1939/R   SLYHAA
World Clinical Drug
World Clinical Drug ›› 2015, Vol. 36 ›› Issue (11) : 752-758. DOI: 10.13683/j.wph.2015.11.008
Article

Combination of S1, a novel PI3K/mTOR dual inhibitor, with sorafenib to treat small cell lung cancer

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2015, 36(11): 752-758 https://doi.org/10.13683/j.wph.2015.11.008

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉